
Sign up to save your podcasts
Or


Is it time to rethink perioperative immunotherapy in resectable gastric and gastroesophageal junction (GEJ) cancers? See the latest data and expert takeaways. Credit available for this activity expires: 7/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002710?ecd=bdc_podcast_libsyn_mscpedu
By Medscape Podcasts4
77 ratings
Is it time to rethink perioperative immunotherapy in resectable gastric and gastroesophageal junction (GEJ) cancers? See the latest data and expert takeaways. Credit available for this activity expires: 7/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002710?ecd=bdc_podcast_libsyn_mscpedu

141 Listeners

322 Listeners

557 Listeners

501 Listeners

1,310 Listeners

300 Listeners

257 Listeners

881 Listeners

13 Listeners

16 Listeners

296 Listeners

261 Listeners

3,370 Listeners

203 Listeners

92 Listeners

514 Listeners

61 Listeners

27 Listeners

249 Listeners